Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Patient-Reported Outcomes, Response to Therapy and Lung Function

類似資料

• Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Exacerbation Endpoints
  著者:: Bafadhel, M, 等
  出版事項: (2018)
• Mepolizumab for eosinophilic COPD
  著者:: Sciurba, F, 等
  出版事項: (2018)
• Mepolizumab for eosinophilic chronic obstructive pulmonary disease
  著者:: Pavord, I, 等
  出版事項: (2017)
• Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD
  著者:: Pavord, I, 等
  出版事項: (2017)
• Evaluation of potential continuation rules for mepolizumab treatment of severe eosinophilic asthma.
  著者:: Gunsoy, N, 等
  出版事項: (2017)